The lifestyle guru appeared on The Tonight Show on Monday night (January 27), where host Jimmy Fallon asked her if she would ...

Martha Stewart is still dreaming of appearing on Saturday Night Live. On a new episode of The Tonight Show Starring Jimmy ...

stemming from selling her stake in ImClone Systems, a biopharmaceutical company, in December 2001. She was released from prison in March 2005. Despite not appearing on SNL at the time, Stewart was ...

The scandal has been disturbing to the biotechnology and pharmaceutical industries, in part because it echoes the debacle that rocked ImClone Systems not long ago. Sam Waksal, ImClone's former CEO, is ...

Inc., ImClone Systems Incorporated, and OSI Pharmaceuticals; and is a member of the Speaker's Bureau for Genentech, Inc. Dr. Schiller has received research funding from Celgene Corporation.

However, it all crumbled when Stewart was accused of insider trading after selling her shares in ImClone Systems in 2001. Related: How Al Pacino went from a net worth of $50 million to broke ...

Other companies that joined the ranks of top revenue gainers in 2006 included Amylin, which launched its first two products in 2005, and oncology firms Celgene and ImClone Systems (New York).

This way, even if they receive insider information, such insider trading would be legal. For a good reason, Martha Stewart’s ImClone Systems’ stock sale is likely the most widely known insider trading ...

Kim’s career also includes leadership roles at ImClone Systems, OSI Pharmaceuticals, Domain Associates and Safeguard Scientifics. He holds a master’s degree from The Wharton School and a bachelor of ...

Mr. Kim’s career also includes leadership roles at ImClone Systems, OSI Pharmaceuticals, Domain Associates, and Safeguard Scientifics. Mr. Kim holds an MBA from The Wharton School and a Bachelor of ...